Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Long noncoding RNA uc.230/CUG-binding protein 1 axis sustains intestinal epithelial homeostasis and response to tissue injury
Ting-Xi Yu, … , Jean-Pierre Raufman, Jian-Ying Wang
Ting-Xi Yu, … , Jean-Pierre Raufman, Jian-Ying Wang
Published October 10, 2022
Citation Information: JCI Insight. 2022;7(19):e156612. https://doi.org/10.1172/jci.insight.156612.
View: Text | PDF
Research Article Gastroenterology

Long noncoding RNA uc.230/CUG-binding protein 1 axis sustains intestinal epithelial homeostasis and response to tissue injury

  • Text
  • PDF
Abstract

Intestinal epithelial integrity is commonly disrupted in patients with critical disorders, but the exact underlying mechanisms are unclear. Long noncoding RNAs transcribed from ultraconserved regions (T-UCRs) control different cell functions and are involved in pathologies. Here, we investigated the role of T-UCRs in intestinal epithelial homeostasis and identified T-UCR uc.230 as a major regulator of epithelial renewal, apoptosis, and barrier function. Compared with controls, intestinal mucosal tissues from patients with ulcerative colitis and from mice with colitis or fasted for 48 hours had increased levels of uc.230. Silencing uc.230 inhibited the growth of intestinal epithelial cells (IECs) and organoids and caused epithelial barrier dysfunction. Silencing uc.230 also increased IEC vulnerability to apoptosis, whereas increasing uc.230 levels protected IECs against cell death. In mice with colitis, reduced uc.230 levels enhanced mucosal inflammatory injury and delayed recovery. Mechanistic studies revealed that uc.230 increased CUG-binding protein 1 (CUGBP1) by acting as a natural decoy RNA for miR-503, which interacts with Cugbp1 mRNA and represses its translation. These findings indicate that uc.230 sustains intestinal mucosal homeostasis by promoting epithelial renewal and barrier function and that it protects IECs against apoptosis by serving as a natural sponge for miR-503, thereby preserving CUGBP1 expression.

Authors

Ting-Xi Yu, Sudhakar Kalakonda, Xiangzheng Liu, Naomi Han, Hee K. Chung, Lan Xiao, Jaladanki N. Rao, Tong-Chuan He, Jean-Pierre Raufman, Jian-Ying Wang

×

Figure 2

uc.230 is required for IEC renewal.

Options: View larger image (or click on image) Download as PowerPoint

uc.230 is required for IEC renewal.
(A) Levels of uc.230 in Caco-2 cell...
(A) Levels of uc.230 in Caco-2 cells 48 hours after transfection with anti-uc.230 or control oligo (control) were measured by qPCR. Values are the means ± SEM (n = 4). *P < 0.05 compared with control. (B) Cell growth after uc.230 silencing in vitro. Equal numbers of cells were seeded in 24-well plates 24 hours after transfection. *P < 0.05 compared with control (n = 3). (C) Relative G1, S, and G2/M compartments of the cell cycle were calculated from flow cytometric analysis on day 4 after anti-uc.230 transfection. *P < 0.05 compared with control (n = 3). (D) Expression levels of cyclin D1 and CDK4 in cells described in C. (E) Growth of enteroids after uc.230 silencing ex vivo. Top, confocal analysis of BrdU (red) and DAPI (blue) on day 4 after culture; and bottom, bright field microscopy analysis of enteroids sizes. Scale bars: 100 μm. (F) Quantification of BrdU (n = 6) and surface area (n = 5) of enteroids described in E. *P < 0.05 compared with control. (G) Levels of uc.230 in cells transfected with the uc.230 expression vector (right) for 48 hours. *P < 0.05 compared with cells control vector (n = 5). (H) Cell growth on days 2 and 4 after uc.230 overexpression (O/E) (n = 3). In A, C, F, G, and H, statistical significance was analyzed using unpaired, 2-tailed Student’s t tests. In B, statistical comparison between time-course curves was by 2-way ANOVA with Bonferroni post hoc test.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts